TREM2 and Alzheimer disease: Moreover, SNPs in the MS4A4A gene were shown to modulate the soluble TREM‐2 concentration in the cerebrospinal fluid of Alzheimer's disease (AD) patients, which increased levels are usually associated with reduced disease risk and delayed age at onset of disease.27